← Back to Search

Behavioural Intervention

Healthy Lifestyle Program for Young Cancer Survivors (HEALTHY-AYA Trial)

N/A
Recruiting
Led By Caroline S Dorfman, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will study ways to help AYA cancer survivors manage weight, symptoms and CVD risk. Healthy eating & physical activity are key behaviors for weight loss &may protect against CVD.

Who is the study for?
This trial is for young adults aged 18-39 who had cancer and are within 2 years of completing treatment. Participants should have a BMI over 30, be healthy enough to do home-based exercise, and must understand English well enough to give informed consent.
What is being tested?
The study tests 'HEALTHY AYA', a program designed to help these survivors manage their weight and reduce cardiovascular risk through better eating habits and physical activity. It's compared with an education control group in a pilot randomized controlled trial.
What are the potential side effects?
Since the interventions involve lifestyle changes like diet modification and increased physical activity, side effects may include muscle soreness or injury from exercise, dietary changes discomforts but typically no severe side effects are expected.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of study recruitment
Intervention acceptability: Treatment Acceptability Questionnaire
Intervention satisfaction: SSTS-R
+3 more
Secondary study objectives
Change in Anxiety: PROMIS Anxiety Short Form
Change in Depressive Symptoms: PROMIS Depression Short Form
Change in Fatigue: PROMIS Fatigue Scale
+5 more
Other study objectives
Change in Atherosclerotic Cardiovascular Disease (ASCVD) risk
Change in HDL
Change in LDL
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: HEALTHY AYAExperimental Treatment1 Intervention
Participants randomized to the intervention arm will receive an 8 session intervention providing instruction in cognitive and behavioral symptom coping strategies as well as behavioral strategies to improve diet and decrease sedentary time.
Group II: Education ControlExperimental Treatment1 Intervention
Participants randomized to the education control arm will receive information about topics of relevance to adolescent and young adult cancer survivors including sleep, cognitive problems, finances, sexual health, and return to work/school.

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,455 Previous Clinical Trials
2,971,516 Total Patients Enrolled
Caroline S Dorfman, PhDPrincipal InvestigatorDuke University
2 Previous Clinical Trials
127 Total Patients Enrolled
~6 spots leftby Jan 2025